Previously studies have shown that through intracellular signal transduction, TLR ligands in brain tissue activate TLRs (22), mainly TLR-3 and TLR-4 (23), leading to increased secretion of inflammatory factors IFN-γ and IL-17, which directly contribute to the onset of MS. Here, TLR3 is linked to myeloid sarcoma.